(Q74642918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Patient dropouts before completion of optimal dose, multiple allergen immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Rhodes BJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

281-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

Immunotherapy with allergens

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Determinants of patient compliance with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Systemic reactions from allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

The safety of allergenic immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts. AAAI Board of Directors. American Academy of Allergy and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Fatalities from immunotherapy (IT) and skin testing (ST)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Survey of fatalities from skin testing and immunotherapy 1985-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Immunotherapy for cat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

Late systemic-allergic reactions to inhalant allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962609-9

7 January 2021

10.1016/S1081-1206(10)62609-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094219%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference